Publications by authors named "Nathan J Robison"

Claim this Profile
A
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4.
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, Shelly Lensing, Azra H Ligon, Nathan J Robison

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu, Nathan J Robison

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.
Audrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, Elke Pfaff, Pouneh Amir-Yazdani, Nathan J Robison

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
Patricia O'Hare, Tabitha Cooney, Peter de Blank, David H Gutmann, Mark Kieran, Nathan J Robison

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective re-induction regimen for children with recurrent medulloblastoma.
Katrina O'Halloran, Sheetal Phadnis, Gregory K Friedman, Katie Metrock, Tom B Davidson, Nathan J Robison

Neurooncol Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group.
Sabine Mueller, Jason Fangusaro, Arzu Onar Thomas, Thomas S Jacques, Pratiti Bandopadhayay, Nathan J Robison

Neuro Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J Peer, Nathan J Robison

Neuro Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Nathan J Robison

Oncotarget· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Function in Children and Young Adults Treated with MEK Inhibitors: A Retrospective Cohort Study.
Nathan J Robison, Jennifer A Su, Melody J Fang, Jemily Malvar, Jondavid Menteer

Pediatr Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Gliosarcoma With and Without Neurofibromatosis Type 1: A Whole-exome Comparison of 2 Patients.
Richard T Graham, Erica H Bell, Amy Webb, Yue Zhao, Cynthia Timmers, Nathan J Robison

J Pediatr Hematol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Nicole J Ullrich, Sanjay P Prabhu, Roger J Packer, Stewart Goldman, Nathan J Robison

Pediatr Blood Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
Brian D Weiss, Pamela L Wolters, Scott R Plotkin, Brigitte C Widemann, James H Tonsgard, Nathan J Robison

J Clin Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of comprehensive genomic profiling in central nervous system tumors of children and young adults.
Jianling Ji, Kristiyana Kaneva, Matthew C Hiemenz, Girish Dhall, Tom Belle Davidson, Nathan J Robison

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.
Stewart Goldman, Ian F Pollack, Regina I Jakacki, Catherine A Billups, Tina Y Poussaint, Nathan J Robison

Neuro Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.
Nicole J Ullrich, Sanjay P Prabhu, Alyssa T Reddy, Michael J Fisher, Roger Packer, Nathan J Robison

Neuro Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Jason Fangusaro, Olaf Witt, Pablo Hernáiz Driever, Asim K Bag, Peter de Blank, Nathan J Robison

Lancet Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.
Kee Kiat Yeo, Ashley S Margol, Rebekah J Kennedy, Long Hung, Nathan J Robison

J Neurooncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained response of three pediatric BRAF mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy.
Stephanie A Toll, Hung N Tran, Jennifer Cotter, Alexander R Judkins, Benita Tamrazi, Nathan J Robison

Oncotarget· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children's Oncology Group.
Ashley S Margol, Kee Kiat Yeo, Caihong Xia, Arzu Onar, Nathan J Robison

J Neurooncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma.
Nalin Gupta, Liliana C Goumnerova, Peter Manley, Susan N Chi, Donna Neuberg, Nathan J Robison

Neuro Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.
Nathan J Robison, Kee Kiat Yeo, Adrian P Berliner, Jemily Malvar, Michael A Sheard

J Neurooncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor.
Erin N Kiehna, Maxine R Arnush, Benita Tamrazi, Jennifer A Cotter, Debra Hawes, Nathan J Robison

J Neurosurg Pediatr· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy.
Stefan Blüml, Ashley S Margol, Richard Sposto, Rebekah J Kennedy, Nathan J Robison

Neuro Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-associated macrophages in SHH subgroup of medulloblastomas.
Ashley S Margol, Nathan J Robison, Janahan Gnanachandran, Long T Hung, Rebekah J Kennedy

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse intrinsic pontine glioma: a reassessment.
Nathan J Robison, Mark W Kieran

J Neurooncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis